Barbara Kołodziej

University of Life Sciences in Lublin

Danuta Sugier

University of Life Sciences in Lublin


Roseroot, Rhodiola rosea L. has been used in the traditional Asian, Scandinavian and Eastern European medicine for centuries as remedies for improvement of physical condition, treatment of anemia, depression, asthenia, impotence, gastro-intestinal and nervous system disorders and also as a immunostimulant and anti-inflammatory agent. This valuable plant grows naturally in Himalayas, Altai, Alps and the Carpatian mountains. Roseroot raw material contains phenylethanoids (salidroside and p-tyrosol) and cinnamic glycosides known as phenylpropanoids (rosin, rosavin and rosarin), that are considered the most important active substances identified in raw material. The objective of this experiment was to compare the content of phenolic compounds (salidroside, p-tyrosol) and cinnamic glycosides (rosarin, rosavin and rosin) determined by HPLC method, from particular morphological parts (roots, rhizomes, and for the first time – tips
and above ground parts) of the raw material of R. rosea cultivated in Poland through seven following vegetation periods. In this study we found that significantly yearly increases in total phenylethanoids and phenylpropanoids concentrations occur with R. rosea grown in Poland. Rhizomes were characterized by highest amount of phenylpropanoids and phenylethanoids studied, in comparison to the other morphological parts of plants at the same age, whereas a certain amount of active substances were also found in the stems and leaves of Rhodiola rosea (on an average as twice as lower than in the under ground parts of plants). Thus, above ground parts of roseroot could be a potential source of phenylethanoids and phenylpropanoids for pharmacy. Roseroot harvested after only 3 year of vegetation contained significantly lower amounts of phenylethanoids and phenylpropanoids in under ground parts of plants than harvested after 4, 5 or 6 year. Since
these phenolics and glycosides are the major active constituents of Rhodiola rosea, this change to an earlier harvest (before fourth or in appropriate cases in third year) may have an effect on the quality of the harvested raw material.


morphological parts, quality of raw material, phenylpropanoids and phenylethanoids content

Altantsetseg K., Przybył J.L., Węglarz Z., Geszprych A., 2007. Content of biologically active compounds in roseroot (Rhodiola sp.) raw material of different derivation. Herba Pol., 53 (4), 20–26.
Brown R.P., Gerbarg P.L., Ramazanov Z., 2002. Rhodiola rosea: a phytomedicinal overview. Herbal Gram, 56, 40–52.
Bykov V.A., Zapesochnaya G.G., Kurkin V.A., 1999. Traditional and biotechnological aspects of obtaining medicinal preparations from Rhodiola rosea l. (a review). Pharm. Chem. J. 33(1), 29–40.
Buchwald W., Mścisz A., Krajewska-Patan A., Furmanowi M., Mielcarek S., Mrozikiewicz P.M., 2006. Contents of biologically active compounds in Rhodiola rosea roots during the vegetation period. Herba Pol. 52, 39–43.
Galambosi B., 2006. Demand and availability of Rhodiola rosea L. raw material. Bogers R.,Cracer L., Lange D. (eds.) Medicinal and Aromatic Plants. Springer, 223–236.
Ganzera M., Yayla Y., Khan I.A., 2000. Analysis of the marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography. Arch. Pharm. Res. 23(4), 349–352.
Kędzia B., Furmanowa M., Krajewska-Patan A., Hołderna-Kędzia H., Mścisz A., Wójcik J., 2006. Badania nad toksycznością oraz działaniem adaptogennym i przeciwdrobnoustrojowym wyciągów otrzymanych z podziemnych części wybranych gatunków Rhodiola L. Herba Pol., 52, 117–32.
Kiryanov, A.A., Bondarenko L.T., Kurkin V.A., Zapesochnaya G.G., Dubichev A.A., Vorontsov E.D., 1991. Determination of biologically active components of the rhizomes of Rhodiola rosea. Khim. Prir. Soedin. 3, 320–323.
Kołodziej B., Sugier D., 2012. Selected elements of biology and morphology of roseroot in southeastern Poland. Acta Sci. Pol. Ser. Hortorum Cultus 11(5), 127–142.
Krajewska-Patan A., Dreger M., Górska-Paukszta M., Łowicka A., Furmanowa M., Mrozikiewicz P.M., 2005. Rhodiola rosea L. – present status of biotechnology investigations. Herba Pol. 51(3/4), 51–64.
Kucharski W., Mordalski R., Buchwald W., Mielcarek S.: Roseroot – the comparison of tillage in conventional and ecological system. J. Res. Appl. Agric. Eng. 2011, 56(3), 232–235.
Kurkin V.A., 2003. Phenylpropanoids from medicinal plants: distribution, classification, structural analysis and biological activity. Chem. Nat. Comp. 39(2), 123–153.
Kurkin V.A., Zapesochanaya G.G., Gorbunov Y.N., Nukhimovskii E.L., Shreter A.I., Shchavlinskii A.N., 1986. Chemical investigations on some species of Rhodiola L. and Sedum L. genera and problemes of their chemotaxonomy. Rast. Res. 22 (3), 310–319.
Lange, D., 1998. Europe’s Medicinal and Aromatic Plants: Their Use, Trade and Conservation. TRAFFIC International, Cambridge, United Kingdom.
Linh P.T., Kim Y.H., Hong S.P., Jian J.J., Kang J.S., 2000. Quantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by HPLC. Arch. Pharm. Res., 23, 349–52.
Ma C.Y., Tang J., Wang X., Gu X., Tao G.J., 2008. Simultaneous determination of six active compounds in Rhodiola rosea L. by RP-LC. Chromatographia 67 (5/6), 383–388.
Panosian A., Wikman G., Sarris J., 2010. Roseroot (Rhodiola rosea L.): traditional use, chemical composition, pharmacology and clinical efficiacy. Phytomed, 17, 481–493.
Platikanov S., Evstatieva L., 2008. Introduction of wild golden root (Rhodiola rosea L.) as a potential economic crop in Bulgaria. Economic Botany 64(4), 621–627.
Przybył J., Węglarz Z., Pawełczak A., 2004. Zmienność w obrębie populacji różeńca górskiego (Rhodiola rosea L.) pod względem plonu surowca i zawartości związków biologicznie czynnych. Zesz. Probl. Post. Nauk Roln. 497, 525–31.
Przybył J., Węglarz Z., Geszprych A., 2008. Quality of roseroot (Rhodiola rosea L.) cultivated in Poland. Acta Hort., 765, 143–150.
Revina T.A., Krasnov E.A., Sviridova T.P., Stepanyuk G.Y., Surov Y.P., 1976. Biological characteristics and chemical composition of Rhodiola rosea grown in Tomsk. Rast. Res. 12(3), 355–360.
Węglarz Z., Przybył J., Geszprych A., 2008. Roseroot (Rhodiola rosea L.): Effect of internal and external factors on accumulation of biologically active compounds. In: Ramawat K.G., Merillon J.M. (eds.): Bioactive Molecules and Medicinal Plants. Berlin, Heidelberg., 16, 297–315.
Zapesochanaya G.G., Kurkin V.A., 1983. Glycosides of cinnamyl alcohol from the rhizomes of Rhodiola rosea. Chem. Nat. Comp. 18 (6), 685–688.
Zapesochnaya G. G., Kurkin V.A., 1982. Cinnamic glycosides of Rhodiola rosea rhizomes. Khim. Prir. Soed. 6, 723–727.


Barbara Kołodziej 
University of Life Sciences in Lublin
Danuta Sugier 
University of Life Sciences in Lublin



Articles are made available under the conditions CC BY 4.0 (until 2020 under the conditions CC BY-NC-ND 4.0).
Submission of the paper implies that it has not been published previously, that it is not under consideration for publication elsewhere.

The author signs a statement of the originality of the work, the contribution of individuals, and source of funding.


Most read articles by the same author(s)

1 2 > >>